---
figid: PMC4816192__cddis2015419f1
figlink: /pmc/articles/PMC4816192/figure/fig1/
number: F1
caption: Targeting of BCR and PI3K/AKT signaling as therapeutic strategy in CLL. BCR
  signaling has a major role in the development of CLL. After antigen ligation on
  BCR, three main protein tyrosine kinases, LYN, SYK and BTK, are activated. PLC2
  and PI3K are important downstream effectors of BCR signaling. PI3K activates downstream
  kinases such as AKT, which in turn induces NFkB and mTOR routes. Activation of PLC2
  leads to the release of intracellular Ca2+ and activation of PKC, both of which
  are crucial for the activation of mitogen-activated protein kinases (MAPKs), such
  as ERK, c-JUN NH2-terminal kinase (JNK) and p38 MAPK and transcription factors,
  including NFκB. PI3K/AKT pathway can be induced also by tyrosine kinase receptors
  such as IGFR1 and ROR1. TCL1 enhances AKT signal and can sustain activation of the
  BCR downstream factors SYK and LYN by indirect inhibition of the phosphatase PTPROt.
  Red symbols and letters indicate new therapeutic targets as discussed in the text
pmcid: PMC4816192
papertitle: TCL1 transgenic mouse model as a tool for the study of therapeutic targets
  and microenvironment in human B-cell chronic lymphocytic leukemia.
reftext: A Bresin, et al. Cell Death Dis. 2016 Jan;7(1):e2071.
pmc_ranked_result_index: '112978'
pathway_score: 0.9714502
filename: cddis2015419f1.jpg
figtitle: Targeting of BCR and PI3K/AKT signaling as therapeutic strategy in CLL
year: '2016'
organisms:
- Homo sapiens
ndex: df73f21d-dec6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4816192__cddis2015419f1.html
  '@type': Dataset
  description: Targeting of BCR and PI3K/AKT signaling as therapeutic strategy in
    CLL. BCR signaling has a major role in the development of CLL. After antigen ligation
    on BCR, three main protein tyrosine kinases, LYN, SYK and BTK, are activated.
    PLC2 and PI3K are important downstream effectors of BCR signaling. PI3K activates
    downstream kinases such as AKT, which in turn induces NFkB and mTOR routes. Activation
    of PLC2 leads to the release of intracellular Ca2+ and activation of PKC, both
    of which are crucial for the activation of mitogen-activated protein kinases (MAPKs),
    such as ERK, c-JUN NH2-terminal kinase (JNK) and p38 MAPK and transcription factors,
    including NFκB. PI3K/AKT pathway can be induced also by tyrosine kinase receptors
    such as IGFR1 and ROR1. TCL1 enhances AKT signal and can sustain activation of
    the BCR downstream factors SYK and LYN by indirect inhibition of the phosphatase
    PTPROt. Red symbols and letters indicate new therapeutic targets as discussed
    in the text
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RAF1
  - KRAS
  - MAPK3
  - CD79A
  - BLNK
  - MAPK10
  - ARAF
  - BRAF
  - CHRFAM7A
  - MAPK1
  - PRKCH
  - AKT2
  - PRKCA
  - MAPK9
  - LYN
  - MTOR
  - BCR
  - PRKCQ
  - IGF1R
  - NRAS
  - NFKB1
  - PRKCI
  - PRKCG
  - AKT1
  - TCL1A
  - IKBKB
  - MAPK8
  - PRKCZ
  - PLCG2
  - PRKCE
  - PRKD3
  - AKT3
  - CHUK
  - PRKCD
  - IKBKG
  - SYK
  - PRKCB
  - ROR1
  - HRAS
  - PF-04691502
  - RAPAMYCIN
  - Cancer
genes:
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Iga
  symbol: IGA
  source: hgnc_prev_symbol
  hgnc_symbol: CD79A
  entrez: '973'
- word: BLNK
  symbol: BLNK
  source: hgnc_symbol
  hgnc_symbol: BLNK
  entrez: '29760'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: D10
  symbol: D-10
  source: hgnc_alias_symbol
  hgnc_symbol: CHRFAM7A
  entrez: '89832'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: LYN
  symbol: LYN
  source: hgnc_symbol
  hgnc_symbol: LYN
  entrez: '4067'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: IGF1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TCL1
  symbol: TCL1
  source: hgnc_alias_symbol
  hgnc_symbol: TCL1A
  entrez: '8115'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PLCY2
  symbol: PLCG2
  source: hgnc_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: ROR1
  symbol: ROR1
  source: hgnc_symbol
  hgnc_symbol: ROR1
  entrez: '4919'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals:
- word: PF-04691502
  source: MESH
  identifier: C570662
- word: RAPAMYCIN
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4816192__F1
redirect_from: /figures/PMC4816192__F1
figtype: Figure
---
